1-3 of 3
Chris Tse, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Study of ABT-348, A Dual Aurora/VEGF-Receptor Kinase Inhibitor, in Patients with Advanced Hematologic Malignancies.

Guillermo Garcia-Manero, MD, Raoul Tibes, MD, Yi-Lin Chiu, PhD, Hao Xiong, PhD, Qin Qin, Peter Ansell, PhD, Daniel H. Albert, PhD, BSc, Chris Tse, PhD, Brian Oliver, Karim Sajwani, MS, Mark D. McKee, MD, Justin L. Ricker, MD, PhD, H. Jean Khoury, MD
Journal: Blood
Blood (2012) 120 (21): 2617.
https://doi.org/10.1182/blood.V120.21.2617.2617
Published: 2012
Journal Articles

The Bcl-2 Family Protein Inhibitor, ABT-263, Promotes Apoptotic-Like Response in Isolated Platelets.

Chris Tse, PhD, Haichao Zhang, PhD, Jun Chen, PhD, Ryan M. Fryer, PhD, Richard Nelson, Paul Nimmer, Glenn A. Reinhart, PhD, Morey L. Smith, Stephen K. Tahir, PhD, Saul H. Rosenberg, PhD, Steven W. Elmore, PhD
Journal: Blood
Blood (2006) 108 (11): 1122.
https://doi.org/10.1182/blood.V108.11.1122.1122
Published: 2006
Journal Articles

Bcl-2 Family Protein Inhibitors Induce a Unique Thrombocytopenia In Vivo .

Steven W. Elmore, PhD, Joy Bauch, Ryan M. Fryer, PhD, Laurie Iciek, PhD, Kennan Marsh, PhD, Sherry J. Morgan, PhD, DVM, Richard Nelson, Glenn A. Reinhart, PhD, Morey L. Smith, Chris Tse, PhD, Saul H. Rosenberg, PhD
Journal: Blood
Blood (2006) 108 (11): 4236.
https://doi.org/10.1182/blood.V108.11.4236.4236
Published: 2006